Insmed (INSM)

Add to Watchlists
Create an Alert
12.57 -0.99  -7.30% NASDAQ Apr 15, 8:00PM BATS Real time Currency in USD
View Full Chart
INSM Price Chart
View All Events

INSM Events

Date Type Description
Mar 06 Earnings Insmed, Inc. Q4 2013 Earnings Results. Estimate: -0.40.
Nov 05 Misc Insmed to Host Third Quarter 2013 Financial Results Conference Call
Nov 05 Earnings Insmed to Host Third Quarter 2013 Financial Results. Estimate: -0.34.
Aug 06 Misc Insmed to Host Second Quarter 2013 Financial Results Conference Call on Tuesday, August 6, 2013
Aug 06 Earnings Insmed Announces Second Quarter 2013 Financial Results. Estimate: -0.42.
May 23 Misc AGM Event for Insmed Inc
May 07 Misc Insmed to Host First Quarter 2013 Financial Results Conference Call on Tuesday, May 7, 2013
May 07 Earnings Nsmed to Host First Quarter 2013 Financial Results Conference Call on Tuesday, May 7, 2013. Estimate: -0.38.
View All Performance Charts

INSM Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Insmed is up 71.72% over the last year vs S&P 500 Total Return up 21.24%, Alexion Pharmaceuticals up 51.13%, and Alkermes up 74.89%.

Get Quote for

Pro Report PDF for INSM

Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download INSM Pro Report PDF
Advertisement

Pro Strategies Featuring INSM

Did Insmed make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.

INSM Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: New Jersey
  • Incorporation Country: United States
  • Incorporation State/Province: Virginia
  • Current Fiscal Year End: December 31, 2014
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Insmed, Inc. is a biopharmaceutical company engaged in developing and commercializing inhaled therapies for patients battling serious lung diseases that are often life threatening. Its lead product candidate is ARIKAYCE.

Recent Quotes

Symbol Price Chg Chg % Market Cap
INSM 12.57 -0.99 -7.30% 493.55M
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.